Opportunity Information: Apply for HT9425 23 OCRP CTRA
The Ovarian Cancer Clinical Translational Research Award (Funding Opportunity Number HT9425 23 OCRP CTRA) is a Department of Defense program administered through the Department of the Army (USAMRAA) that supports translational research tightly connected to a clinical trial in ovarian cancer. The central purpose is to fund correlative studies that use clinical trial-linked patient data and specimens to identify and validate relationships between biological or contextual factors and meaningful ovarian cancer outcomes. These factors can include genetic changes, biochemical markers, environmental exposures, and other measurable variables that may influence how ovarian cancer starts, progresses, spreads (metastasis), returns (recurrence), or responds to an intervention. The emphasis is on translational work that can move the field toward more actionable clinical insights, especially in areas where there are clear gaps or unmet needs.
A defining feature of this award is the requirement that the research be associated with a clinical trial that is past, currently ongoing, or planned for the future. Rather than funding a standalone laboratory project, the mechanism is meant to leverage the clinical trial setting where patient populations are well-defined, treatments and outcomes are tracked, and biospecimens may be available with strong clinical annotation. The goal is to connect what is observed in patients (such as treatment response, survival, recurrence patterns, or adverse effects) with molecular or other correlates that can improve prognosis, diagnosis, or therapeutic decision-making.
The types of activities envisioned under this opportunity include deeper molecular analysis of clinical samples collected through trials, validation of candidate biomarkers, and extended clinical follow-up of patients who were enrolled in trials that are still open, ongoing, or already completed. Projects can be structured as hypothesis-driven studies that test specific predictions, or as efforts that generate broadly useful resources for the ovarian cancer research community. Examples of these resource-oriented outputs include clinically annotated tissue arrays and patient-derived experimental platforms (such as patient-derived models), where specimens are paired with detailed clinical metadata and molecular characterization to enable future discovery and validation work.
From an administrative standpoint, this opportunity is listed as a discretionary program in the Science and Technology and other Research and Development category (CFDA 12.420). The eligible applicant pool is described as unrestricted, meaning it is broadly open to different types of entities, subject to any additional eligibility clarifications in the full announcement. The funding instruments include grants and cooperative agreements, indicating that awards could involve either a more traditional investigator-led structure or a model with closer government involvement depending on the specific award conditions. The opportunity was created on March 7, 2023, with an original closing date of July 21, 2023, and it anticipated making one award; the published award ceiling is listed as 0, which typically signals that the maximum funding level was not specified in the summary record and would need to be confirmed in the full solicitation.
Overall, the program is designed to accelerate clinically relevant ovarian cancer discoveries by tying molecular and other correlates directly to clinical trial contexts, with the intent of producing insights and tools that can inform diagnosis, prognosis, patient stratification, and the real-world impact of interventions.Apply for HT9425 23 OCRP CTRA
- The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "Ovarian Cancer Clinical Translational Research Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
- This funding opportunity was created on Mar 07, 2023.
- Applicants must submit their applications by Jul 21, 2023. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the Ovarian Cancer Clinical Translational Research Award (CTRA)?
The Ovarian Cancer Clinical Translational Research Award (Funding Opportunity Number HT9425 23 OCRP CTRA) is a Department of Defense research program administered through the Department of the Army (USAMRAA). It supports translational ovarian cancer research that is tightly connected to a clinical trial, with a central focus on correlative studies that link patient data and specimens to meaningful clinical outcomes.
What is the main purpose of this funding opportunity?
The central purpose is to fund correlative studies that use clinical trial-linked patient data and biospecimens to identify and validate relationships between biological or contextual factors and ovarian cancer outcomes. The goal is to move toward more actionable clinical insights, especially where there are clear gaps or unmet needs.
What does "translational research" mean in the context of this award?
In this program, translational research means work that connects observations in patients (such as response to treatment, survival, recurrence, or adverse effects) with molecular or other correlates derived from clinical trial-linked samples and data. The intent is to produce findings that can inform diagnosis, prognosis, or therapeutic decision-making in a clinically relevant way.
Is a clinical trial required for an application to be responsive?
Yes. A defining feature of this award is that the proposed research must be associated with a clinical trial that is past, currently ongoing, or planned for the future. The mechanism is not meant to fund a standalone laboratory project that is disconnected from a clinical trial context.
What kinds of clinical trials qualify (past, ongoing, or planned)?
The opportunity allows association with clinical trials that are already completed, currently ongoing, or planned for the future. The key requirement is that the research is tied to a clinical trial context where patient populations are well-defined, treatments and outcomes are tracked, and biospecimens may be available with strong clinical annotation.
What are "correlative studies" in this program?
Correlative studies are analyses that relate measurable factors (for example, molecular features in specimens or other variables) to clinical outcomes observed in the clinical trial setting. This includes identifying and validating relationships between factors and outcomes such as response to an intervention, survival, recurrence patterns, metastasis, or adverse effects.
What types of factors can be studied under this award?
Factors can include genetic changes, biochemical markers, environmental exposures, and other measurable variables that may influence how ovarian cancer starts, progresses, spreads (metastasis), returns (recurrence), or responds to an intervention.
What outcomes is the program trying to connect to these factors?
The program aims to connect factors to meaningful ovarian cancer outcomes, including treatment response, survival, recurrence patterns, metastasis, and adverse effects, as tracked within a clinical trial setting.
What kinds of research activities are envisioned?
Examples of activities include deeper molecular analysis of clinical samples collected through trials, validation of candidate biomarkers, and extended clinical follow-up of patients enrolled in trials that are still open, ongoing, or already completed.
Are projects required to be hypothesis-driven?
Not necessarily. Projects can be structured as hypothesis-driven studies that test specific predictions, or as efforts that generate broadly useful resources for the ovarian cancer research community.
What does it mean to "generate resources" for the research community?
Resource-oriented outputs described in the opportunity include items like clinically annotated tissue arrays and patient-derived experimental platforms (such as patient-derived models). These resources are characterized by specimens paired with detailed clinical metadata and molecular characterization so they can support future discovery and validation work.
What are examples of deliverables mentioned in the opportunity?
The opportunity specifically mentions clinically annotated tissue arrays and patient-derived experimental platforms (including patient-derived models) as examples of outputs that can enable future research, especially when combined with clinical metadata and molecular characterization.
Why does the award emphasize a clinical trial setting?
The clinical trial setting provides well-defined patient populations, tracked treatments and outcomes, and potentially available biospecimens with strong clinical annotation. This structure helps connect laboratory or molecular observations directly to real patient outcomes and intervention effects.
What is the administering organization for this opportunity?
The program is a Department of Defense effort administered through the Department of the Army, specifically via USAMRAA.
What is the program category and assistance listing referenced?
Administratively, the opportunity is listed as a discretionary program in the Science and Technology and other Research and Development category, under CFDA 12.420.
Who is eligible to apply?
The eligible applicant pool is described as unrestricted, meaning it is broadly open to different types of entities, subject to any additional eligibility clarifications that may be provided in the full announcement.
What funding instruments are used for this opportunity?
The opportunity lists grants and cooperative agreements as the funding instruments. This indicates that awards could be made under a traditional investigator-led grant structure or under a cooperative agreement model that may involve closer government involvement, depending on award conditions.
How many awards were anticipated?
The summary indicates the opportunity anticipated making one award.
What was the opportunity timeline in the summary record?
The opportunity was created on March 7, 2023, and the original closing date listed in the summary record was July 21, 2023.
What is the award ceiling for this opportunity?
The published award ceiling is listed as 0 in the summary record. This typically indicates the maximum funding level was not specified in that summary and would need to be confirmed in the full solicitation.
What clinical impact is this program aiming for?
The program is designed to accelerate clinically relevant ovarian cancer discoveries by tying correlates directly to clinical trial contexts. It aims to produce insights and tools that can inform diagnosis, prognosis, patient stratification, and understanding of the real-world impact of interventions.
Browse more opportunities from the same category: Science and Technology and other Research and Development
Next opportunity: Strengthening Governance, Transparency, and Accountability in Panama
Previous opportunity: Fiscal Year (FY) 2023 Emergency Operations Center (EOC) Grant Program - Region 3
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for HT9425 23 OCRP CTRA
Applicants also applied for:
Applicants who have applied for this opportunity (HT9425 23 OCRP CTRA) also looked into and applied for these:
| Funding Opportunity |
|---|
| Ovarian Cancer Clinical Trial Award Apply for HT9425 23 OCRP CTA Funding Number: HT9425 23 OCRP CTA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Specially Adapted Housing Assistive Technology (SAHAT) Grant Program Apply for VA SAHAT 23 08 Funding Number: VA SAHAT 23 08 Agency: Department of Veterans Affairs, VA Loan Guaranty Service Category: Science and Technology and other Research and Development Funding Amount: $200,000 |
| Bangladesh America Maitree Activity Apply for 72038823RFA00004 Funding Number: 72038823RFA00004 Agency: Agency for International Development, Bangladesh USAID-Dhaka Category: Science and Technology and other Research and Development Funding Amount: $48,000,000 |
| Request for Information on Barriers to Historically Black Colleges and Universities (HBCUs) in applying for Nuclear Forensics Research Awards (NFRAs) Apply for RFI DHS 23 CWMD 130 001 Funding Number: RFI DHS 23 CWMD 130 001 Agency: Department of Homeland Security, Office of Procurement Operations - Grants Division Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| 2023 AFRL/RW Partnership Intermediary Agreement (PIA) Apply for FA8651 23 S 0003 Funding Number: FA8651 23 S 0003 Agency: Department of Defense Category: Science and Technology and other Research and Development Funding Amount: $20,000,000 |
| Lake Huron Phosphorous Efflux Apply for W81EWF 23 SOI 0002 Funding Number: W81EWF 23 SOI 0002 Agency: Department of Defense, Engineer Research and Development Center Category: Science and Technology and other Research and Development Funding Amount: $170,000 |
| FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed Apply for RFA FD 23 011 Funding Number: RFA FD 23 011 Agency: Department of Health and Human Services, Food and Drug Administration Category: Science and Technology and other Research and Development Funding Amount: $250,000 |
| DoD Tuberous Sclerosis Complex, Idea Development Award Apply for HT9425 23 TSCRP IDA Funding Number: HT9425 23 TSCRP IDA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Tuberous Sclerosis Complex, Exploration – Hypothesis Development Award Apply for HT9425 23 TSCRP EHDA Funding Number: HT9425 23 TSCRP EHDA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Tuberous Sclerosis Complex, Clinical Translational Research Award Apply for HT9425 23 TSCRP CTRA Funding Number: HT9425 23 TSCRP CTRA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Evaluating Restored Wetland Biogeochemical Cycling Following Thin-layer Sediment Introduction Apply for W81EWF 23 SOI 0003 Funding Number: W81EWF 23 SOI 0003 Agency: Department of Defense, Engineer Research and Development Center Category: Science and Technology and other Research and Development Funding Amount: $60,000 |
| National Institute of Standards and Technology Center for Neutron Research (NCNR) Comprehensive Cooperative Agreement Program Apply for 2023 NIST NCNR 01 Funding Number: 2023 NIST NCNR 01 Agency: Department of Commerce, National Institute of Standards and Technology Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Rehabilitation Research and Training Center (RRTC) on Health and Function Among People with Intellectual and Developmental Disabilities Apply for HHS 2023 ACL NIDILRR RTHF 0025 Funding Number: HHS 2023 ACL NIDILRR RTHF 0025 Agency: Department of Health and Human Services, Administration for Community Living Category: Science and Technology and other Research and Development Funding Amount: $875,000 |
| Fiscal Year (FY) 2023 National Science Portal Pilot (NSPP) Apply for FOA AFRL AFOSR 2023 0009 Funding Number: FOA AFRL AFOSR 2023 0009 Agency: Department of Defense, Air Force Office of Scientific Research Category: Science and Technology and other Research and Development Funding Amount: $4,500,000 |
| Climate Action Partnership for Education (CAPE) Broad Agency Announcement (BAA) Apply for DDI OAA EDUC 2023 Funding Number: DDI OAA EDUC 2023 Agency: Agency for International Development Category: Science and Technology and other Research and Development Funding Amount: $5,000,000 |
| Space-Themed Summer Camp Apply for PAS MOROCCO FY23 07 Funding Number: PAS MOROCCO FY23 07 Agency: Department of State, U.S. Mission to Morocco Category: Science and Technology and other Research and Development Funding Amount: $30,000 |
| Training for Improving Plastics Circularity (TIPC) Grant Program Apply for 2023 NIST TIPC 01 Funding Number: 2023 NIST TIPC 01 Agency: Department of Commerce, National Institute of Standards and Technology Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| FY 2023 Competitive Academic Agreement Program (CAAP) Apply for 693JK323NF0003 Funding Number: 693JK323NF0003 Agency: Department of Transportation, Pipeline and Hazardous Materials Safety Admin Category: Science and Technology and other Research and Development Funding Amount: $1,000,000 |
| Science Foundations for Energy Earthshots Apply for DE FOA 0003003 Funding Number: DE FOA 0003003 Agency: Department of Energy - Office of Science, Office of Science Category: Science and Technology and other Research and Development Funding Amount: $6,000,000 |
| John Ogonowski and Doug Bereuter Farmer-to-Farmer (F2F) Program Apply for 7200AA23RFA00006 Funding Number: 7200AA23RFA00006 Agency: Agency for International Development Category: Science and Technology and other Research and Development Funding Amount: $12,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "HT9425 23 OCRP CTRA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.